<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04659954</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/20/0367</org_study_id>
    <nct_id>NCT04659954</nct_id>
  </id_info>
  <brief_title>Feasibility and Acceptability Study of the &quot;O'Dide&quot; Application in People Suffering From an Addiction</brief_title>
  <acronym>FA-O'DIDE</acronym>
  <official_title>Feasibility and Acceptability Study of the &quot;O'Dide&quot; Application in People Suffering From an Addiction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut de Recherche en Santé Publique, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Substance Use Disorders (SUD) are associated with cognitive schemas that lead to care&#xD;
      attrition and mistrust towards care. Considering this within SUD management, it is important&#xD;
      to establish a confident relation between the patient and the care team to favorize acre&#xD;
      observance. However, it demands an important availability of the healthcare team, allowing&#xD;
      for frequent interactions at all times, including at night and during days off. We postulated&#xD;
      that an application called Ô DIDE for Digital Interaction for Detoxification Engagement, that&#xD;
      aims to help the caregivers maintaining a link with the patient in order to facilitate&#xD;
      confidence in the relationship, could favorize care observance especially consumption report.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present research aims to assess the feasibility of the &quot;Ô DIDE&quot; application after 8 weeks&#xD;
      of use by patients treated for a disorder related to substance use at the Toulouse University&#xD;
      Hospital.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Feasibility of the application O'DIDE</measure>
    <time_frame>8 weeks</time_frame>
    <description>Percentage of patients who logged on at least once a week to the application during the 8 weeks of availability of the O'DIDE application</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Substance-Related Disorders</condition>
  <condition>Personality Disorders</condition>
  <arm_group>
    <arm_group_label>Application O'DIDE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The subjects will use the application O'DIDE during 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Application O'DIDE</intervention_name>
    <description>The intervention is the use of an application that aimed to favorize contact between the patient and the care team between the consultations.</description>
    <arm_group_label>Application O'DIDE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Suffering from any type of addiction, with an active addiction requiring weekly&#xD;
             monitoring of consumption&#xD;
&#xD;
          -  Possessing an Android smartphone or having access to an Android smartphone and having&#xD;
             access to an internet connection&#xD;
&#xD;
          -  Able to read and understand French&#xD;
&#xD;
          -  Affiliated or beneficiary of a social security scheme.&#xD;
&#xD;
          -  Free, informed and written consent signed by the participant and the investigator (at&#xD;
             the latest on the day of inclusion and before any examination required by the&#xD;
             research).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with cognitive or psychiatric disorders that may affect their ability to&#xD;
             consent&#xD;
&#xD;
          -  Participation in another protocol involving a modification of the treatment for&#xD;
             addiction&#xD;
&#xD;
          -  Person under legal protection, guardianship or curatorship&#xD;
&#xD;
          -  Known or suspected pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juliette Salles, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Juliette Salles, MD</last_name>
    <phone>33-561777307</phone>
    <email>salles.j@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital of Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Juliette SALLES, MD</last_name>
    </contact>
    <investigator>
      <last_name>Juliette SALLES, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas NAVARRO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 2, 2020</study_first_submitted>
  <study_first_submitted_qc>December 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2020</study_first_posted>
  <last_update_submitted>December 2, 2020</last_update_submitted>
  <last_update_submitted_qc>December 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>E health</keyword>
  <keyword>Application</keyword>
  <keyword>Substance use disorders</keyword>
  <keyword>Personality disorders</keyword>
  <keyword>Care observance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Personality Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

